Fase
III-data (MAIA) med Darzalex + Rd i nydiagnosticeret knoglemarvskræft

16. oktober 2018

Johnson & Johnson (Janssen) Q3 2018 - Darzalex salg

24. oktober 2018

Symphony Health Solutions - Darzalex-salgstal for september

Q3/Q4 2018

Fase
III-data (Cassiopeia) med Darzalex + Vtd i nydiagnosticeret knoglemarvskræft

Q3/Q4 2018

Annoncere studie i andre cancer-former for tisotumab vedotin

Q3/Q4 2018

Yderligere data for tisotumab vedotin

14. november

Genmab Q3 2018

21. november

Symphony Health Solutions - Darzalex-salgstal for oktober

ASH kræftkonference i San Diego

Symphony Health Solutions - Darzalex-salgstal for november

2019

Fase III-data for Arzerra (ofatumumab) i attakvis multipel sklerose (RRMS)

(markets.sydbank.dk)